Literature DB >> 20618424

Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II.

Carlos Cepeda1, Véronique M André, Irene Yamazaki, Jason S Hauptman, Jane Y Chen, Harry V Vinters, Gary W Mathern, Michael S Levine.   

Abstract

Tuberous sclerosis complex (TSC) and severe cortical dysplasia (CD), or CD type II according to Palmini classification, share histopathologic similarities, specifically the presence of cytomegalic neurons and balloon cells. In this study we examined the morphologic and electrophysiologic properties of cells in cortical tissue samples from pediatric patients with TSC and CD type II who underwent surgery for pharmacoresistant epilepsy. Normal-appearing pyramidal neurons from TSC and CD type II cases had similar passive membrane properties. However, the frequency of excitatory postsynaptic currents (EPSCs) was higher in neurons from TSC compared to severe CD cases, particularly the frequency of medium- and large-amplitude synaptic events. In addition, EPSCs rise and decay times were slower in normal cells from TSC compared to severe CD cases. Balloon cells were found more frequently in TSC cases, whereas cytomegalic pyramidal neurons occurred more often in CD type II cases. Both cell types were similar morphologically and electrophysiologically in TSC and severe CD. These results suggest that even though the histopathology in TSC and severe CD is similar, there are subtle differences in spontaneous synaptic activity and topographic distribution of abnormal cells. These differences may contribute to variable mechanisms of epileptogenesis in patients with TSC compared with CD type II.

Entities:  

Mesh:

Year:  2010        PMID: 20618424      PMCID: PMC2909023          DOI: 10.1111/j.1528-1167.2010.02633.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  21 in total

1.  Neurons recorded from pediatric epilepsy surgery patients with cortical dysplasia.

Authors:  G W Mathern; C Cepeda; R S Hurst; J Flores-Hernandez; D Mendoza; M S Levine
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

2.  Postoperative seizure control and antiepileptic drug use in pediatric epilepsy surgery patients: the UCLA experience, 1986-1997.

Authors:  G W Mathern; C C Giza; S Yudovin; H V Vinters; W J Peacock; D A Shewmon; W D Shields
Journal:  Epilepsia       Date:  1999-12       Impact factor: 5.864

Review 3.  Tuberous sclerosis complex.

Authors:  S P Sparagana; E S Roach
Journal:  Curr Opin Neurol       Date:  2000-04       Impact factor: 5.710

4.  Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex.

Authors:  J Y Wu; N Salamon; H E Kirsch; M M Mantle; S S Nagarajan; L Kurelowech; M H Aung; R Sankar; W D Shields; G W Mathern
Journal:  Neurology       Date:  2010-02-02       Impact factor: 9.910

Review 5.  Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience.

Authors:  Jason T Lerner; Noriko Salamon; Jason S Hauptman; Tonicarlo R Velasco; Marta Hemb; Joyce Y Wu; Raman Sankar; W Donald Shields; Jerome Engel; Itzhak Fried; Carlos Cepeda; Veronique M Andre; Michael S Levine; Hajime Miyata; William H Yong; Harry V Vinters; Gary W Mathern
Journal:  Epilepsia       Date:  2009-01-21       Impact factor: 5.864

6.  Developmental lineage of cell types in cortical dysplasia with balloon cells.

Authors:  Phillip Lamparello; Marianna Baybis; John Pollard; Elly M Hol; David D Eisenstat; Eleonora Aronica; Peter B Crino
Journal:  Brain       Date:  2007-09       Impact factor: 13.501

7.  Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.

Authors:  F E Jansen; O Braams; K L Vincken; A Algra; P Anbeek; A Jennekens-Schinkel; D Halley; B A Zonnenberg; A van den Ouweland; A C van Huffelen; O van Nieuwenhuizen; M Nellist
Journal:  Neurology       Date:  2007-11-21       Impact factor: 9.910

8.  A hypothesis regarding the pathogenesis and epileptogenesis of pediatric cortical dysplasia and hemimegalencephaly based on MRI cerebral volumes and NeuN cortical cell densities.

Authors:  Gary W Mathern; Marissa Andres; Noriko Salamon; P Sarat Chandra; Veronique M Andre; Carlos Cepeda; Michael S Levine; Joao P Leite; Luciano Neder; Harry V Vinters
Journal:  Epilepsia       Date:  2007       Impact factor: 5.864

Review 9.  Tuberous sclerosis.

Authors:  Paolo Curatolo; Roberta Bombardieri; Sergiusz Jozwiak
Journal:  Lancet       Date:  2008-08-23       Impact factor: 79.321

10.  Cytomegalic interneurons: a new abnormal cell type in severe pediatric cortical dysplasia.

Authors:  Véronique M André; Nanping Wu; Irene Yamazaki; Snow T Nguyen; Robin S Fisher; Harry V Vinters; Gary W Mathern; Michael S Levine; Carlos Cepeda
Journal:  J Neuropathol Exp Neurol       Date:  2007-06       Impact factor: 3.685

View more
  11 in total

Review 1.  Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.

Authors:  Michael Wong
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

2.  A pulse rapamycin therapy for infantile spasms and associated cognitive decline.

Authors:  Emmanuel Raffo; Antonietta Coppola; Tomonori Ono; Stephen W Briggs; Aristea S Galanopoulou
Journal:  Neurobiol Dis       Date:  2011-04-12       Impact factor: 5.996

3.  Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.

Authors:  Carlos Cepeda; Véronique M André; Jason S Hauptman; Irene Yamazaki; My N Huynh; Julia W Chang; Jane Y Chen; Robin S Fisher; Harry V Vinters; Michael S Levine; Gary W Mathern
Journal:  Neurobiol Dis       Date:  2011-08-23       Impact factor: 5.996

4.  Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex.

Authors:  B Patel; J Patel; J-H Cho; S Manne; S Bonala; E Henske; F Roegiers; M Markiewski; M Karbowniczek
Journal:  Oncogene       Date:  2015-10-05       Impact factor: 9.867

Review 5.  Basic mechanisms of epileptogenesis in pediatric cortical dysplasia.

Authors:  Sara Abdijadid; Gary W Mathern; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2014-11-18       Impact factor: 5.243

6.  BRAFV600E expression in neural progenitors results in a hyperexcitable phenotype in neocortical pyramidal neurons.

Authors:  Roman U Goz; Gülcan Akgül; Joseph J LoTurco
Journal:  J Neurophysiol       Date:  2020-05-13       Impact factor: 2.714

Review 7.  Epilepsy and epileptic syndrome.

Authors:  Tomonori Ono; Aristea S Galanopoulou
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

8.  Long-term outcomes of epilepsy surgery in tuberous sclerosis complex.

Authors:  Shuli Liang; Juncheng Zhang; Zhixian Yang; Shaohui Zhang; Zhiqiang Cui; Jianfei Cui; Jiwu Zhang; Na Liu; Ping Ding
Journal:  J Neurol       Date:  2017-05-17       Impact factor: 4.849

Review 9.  A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.

Authors:  David M Feliciano; Tiffany V Lin; Nathaniel W Hartman; Christopher M Bartley; Cathryn Kubera; Lawrence Hsieh; Carlos Lafourcade; Rachel A O'Keefe; Angelique Bordey
Journal:  Int J Dev Neurosci       Date:  2013-02-26       Impact factor: 2.457

10.  Paroxysmal Discharges in Tissue Slices From Pediatric Epilepsy Surgery Patients: Critical Role of GABAB Receptors in the Generation of Ictal Activity.

Authors:  Simon Levinson; Conny H Tran; Joshua Barry; Brett Viker; Michael S Levine; Harry V Vinters; Gary W Mathern; Carlos Cepeda
Journal:  Front Cell Neurosci       Date:  2020-03-20       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.